Investor Relations

At our company, we value open and transparent communication with our investors. As a publicly traded company, we understand the importance of keeping our shareholders informed about our performance and financial status. That’s why we make sure to provide regular updates on our website, including financial reports, earnings releases, and other important information.

Additionally, you can find information on our investor relations contacts, upcoming events and presentations, and other resources to help you stay informed about our company’s developments. We are committed to providing our investors with the information they need to make informed decisions about their investment in our company.

Edit Content

Opis działalności spółki

Mycodern SA to polska firma specjalizująca się w produkcji suplementów diety oraz żywności funkcjonalnej, w tym wytwarzaniu żelków witaminowych. W ofercie firmy znajdują się produkty w postaci kapsułek twardych, kapsułek miękkich softgel, napojów funkcjonalnych oraz żelków witaminowych.

Ulica:ul. Jaśkowa Dolina 132/20
Relacje Inwestorskie:Bartosz Groth
Telefon:+48 690 085 985
Email:[email protected]
Nazwa spółki: Mycodern SA
Prezes: Bartosz Groth
EKD: sprzedaż hurtowa pozostałych półproduktów
Liczba akcji: 63 853 170
NIP: 6342351875
KRS: 0000384510
EKD: 46,76
Ticker GPW: MCD
Liczba akcji: 63 853 170 Liczba dużych akcjonariuszy: 4
Liczba głosów na WZA: 6 385 317 Liczba akcji w posiadaniu dużych akcjonariuszy: 57 761 814
Kapitał akcyjny: 6 385 317,00 Procent akcji w posiadaniu dużych akcjonariuszy: 90,46%
Wartość nominalna akcji: 0,10 Liczba głosów w posiadaniu dużych akcjonariuszy: 57 761 814
Free float: 9,54% Procent głosów w posiadaniu dużych akcjonariuszy: 90,46%
Akcjonariusz Liczba akcji % akcji Liczba głosów % głosów Data zmiany
Bartosz Groth 17 401 266 27,25 17 401 266 27,25 2023-03-08
Jacek Wasita 3 415 037 5,35 3 415 037 5,35 2023-03-08
Michał Przyłęcki 19 544 245 30,61 19 544 245 30,61 2023-03-08
Piotr Zawadzki 17 401 266 27,25 17 401 266 27,25 2023-03-08
OpisData WZAEmisjaCena nominalnaCena emisyjnaKapitał po emisji (liczba akcji w tys. szt. / wartość w tys. zł)Data
seria A – przekształcenie sp. z o.o. w SA2011-02-237 100 000
710 000,00
0,100,107 100 000
710 000,00
seria B – przekształcenie sp. z o.o. w SA2011-02-23790 000
79 000,00
0,100,107 890 000
789 000,00
seria C – subskrypcja prywatna2011-10-28975 170
546 095,20
0,100,568 865 170
886 517,00
podział akcji serii A na serie A1 i A2 seria A1-6845000, seria A2-2550002011-10-28    KDPW:
seria D – subskrypcja prywatna2022-11-0454 988 000
27 494 000,00
0,100,506 385 317
63 853 170,00
Nazwisko i imię Funkcja Od dnia Funkcje aktualnie sprawowane w innych spółkach
Bartosz Groth Prezes Zarządu 2023-09-12
Nazwisko i imię Funkcja Od dnia Funkcje aktualnie sprawowane w innych spółkach giełdowych
Lewandowska Katarzyna Członek RN 2022-11-04
Zaręba Michał Członek RN 2022-11-04
Bobrowski Paweł Członek RN 2022-11-04
Darasewicz Mateusz Członek RN 2022-11-04
Wiktoria Groth Członek RN 2023-10-23
Edit Content

Management Board of Mycodern S.A. based in Gdańsk (“Issuer” “Company”), in reference to the report current EBI No. 22/2023 of October 11, 2023 in the scope of the decision taken by the Issuer’s Management Board resolution on increasing the share capital by closed subscription (subscription rights for existing shareholders) within the authorized capital, on Today, an announcement was published in the Court and Economic Monitor terms and conditions of the offer for the purchase of series E shares by existing shareholders and their implementation subscription rights. Detailed information regarding the conditions and procedure for purchasing series shares E and the required documents are posted on the Company’s website at: address: www.mycodern.com.

At the same time, the Issuer’s management board encloses a sample subscription form for series E shares and an information document that has been prepared to comply with the requirements provided for in Article 37a. Act on public offering and conditions of introduction financial instruments for organized trading and public companies.

In order to clarify the subscription procedure, the Issuer’s management informs that for each 1 share of the Company held at the end of the day of determining the pre-emptive rights, the shareholder is entitled to 1 unit pre-emptive right, with 10 individual pre-emptive rights entitling to take up 1 series E share. In the event that the number of series E shares allocated to a given shareholder under rights collection, will not be an integer, it will be rounded down to the nearest number total. The subscription form, a template of which is attached to this report, has three items in which they refer to the number of shares that the investor would like to take up.

In the item regarding the subscription based on the subscription rights held (Basic Subscription), in accordance with the proportion of pre-emptive rights to new issue shares, no more than 1/10 of the number of shares held on the subscription rights date. In the item regarding the Additional Subscription (also based on subscription rights) you can enter: any number of shares, but not greater than the number of all shares offered under this offer issue, i.e. no more than 6,385,317 shares.

In addition, the form includes an item titled: “Invitation of the Management Board to acquire Series E Shares”, which means that even persons who do not hold the Issuer’s shares on the subscription rights date will be able to declare willingness to take up shares that will not be allocated to shareholders under provisions resulting from the subscription rights held. To be sure to all investors Those interested in taking up shares as part of the Management Board’s invitation are advised to send a message with the completed registration form to the following address: [email protected].

If the holder of pre-emptive rights wants to subscribe for new issue shares Primary and Secondary, will be required to complete and submit an enrollment form through the house or brokerage office keeping the account in which they were kept saved and declare the number of shares he would like to take up and then pay immediately all these shares by making a transfer to your brokerage account.

The deadline for exercising the pre-emptive right is November 13, 2023, i.e. no later than a business day earlier the brokerage house or brokerage office must record the payment of the share subscription price. If the total number of subscriptions exceeds the available number of shares, a reduction will be made in proportion to the declarations contained in all submitted and paid forms subscription, and the funds from the investment account transferred by the brokerage house or office the shareholder’s brokerage fees for acquiring shares in the National Depository for Securities will be returned to his account brokerage.

– Bartosz Groth – President of the Management Board


Registration form

MCD - resolution of the Management Board - issue of shares (series E) - change - January 22, 2024

Scroll to Top